RP1

Serial Number 97789358
601

Registration Progress

Application Filed
Feb 10, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RP1
Previous Owner: Replimune Limited
Classes: 005, 042

Trademark Image

RP1

Basic Information

Serial Number
97789358
Filing Date
February 10, 2023
Abandonment Date
October 17, 2023
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
601
Status Date
Oct 18, 2023
Classes
005 042

Rights Holder

Replimune Limited

99
Address
69 Innovation Drive, Milton Park
Abingdon, Oxfordshire OX144RQ
GB

Ownership History

Replimune Limited

Original Applicant
99
Abingdon, Oxfordshire GB

Legal Representation

Attorney
Melanie Howard

Application History

6 events
Date Code Type Description Documents
Oct 18, 2023 MAB1 E ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT Loading...
Oct 17, 2023 EXAR I TEAS EXPRESS ABANDONMENT RECEIVED Loading...
Oct 18, 2023 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Loading...
Oct 18, 2023 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
Mar 1, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 14, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations; viruses; viruses for the treatment of disease; viruses for the treatment of cancer; viruses for inducing immune response; pharmaceuticals; pharmaceuticals for the treatment of cancer; pharmaceuticals for inducing immune response; vaccines; immunotherapy products; gene therapy products; Biological preparations in the nature of viruses for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; biological preparations in the nature of viruses for the treatment of cancer; biological preparations in the nature of viruses for inducing immune response; pharmaceuticals, namely, pharmaceutical preparations and pharmaceutical substances for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals, namely, anti-infectives for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for inducing immune response; vaccines; immunotherapy products, namely, pharmaceutical products for the prevention and treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders; gene therapy products, namely, therapeutics for the treatment of cancer, tumors, infectious, oncological, autoimmune, and immune system diseases and disorders
Class 042
Pharmaceutical drug research and development services; research and development of vaccines and medicines; information, advisory and consultancy services relating to the aforesaid

Additional Information

Pseudo Mark
RP ONE

Classification

International Classes
005 042